Literature DB >> 33528826

Association between high proviral load, cognitive impairment, and white matter brain lesions in HTLV-1-infected individuals.

Rosangela Souza Kalil1,2, Isabelle Vasconcellos2, Carolina Rosadas3, Andrea Cony2, Dulcino P Lima2, Cassia C Alves Gonçalves4, Everton Batista5, Maria Fernanda Grassi5,6, Bernardo Galvão-Castro6, Graham P Taylor3, Marzia Puccioni-Sohler7,8,9.   

Abstract

The association between high proviral load (PVL) in peripheral blood mononuclear cells (PBMC), cognitive disturbance and white matter brain lesions in HTLV-1-infected individuals is still undefined. A cross-sectional study included 62 participants: 22 asymptomatic carriers (mean age 43.4 ± 13.1 years old), 22 patients with HTLV-1-associated myelopathy (HAM/TSP) (mean age 51.5 ± 8.7 years old), and 18 uninfected controls (mean age 52.3 ± 11.1 years old). All individuals fulfilled the following criteria: between 18 and 65 years of age, more than 4 years of formal education, and completed neuropsychological evaluation and HTLV-1 serology. Infected individuals underwent brain conventional magnetic resonance imaging and PVL quantitative PCR (qPCR). Statistical analysis was adjusted in the models by age and education. Cognitive deficit was observed in all groups. Patients with HAM/TSP showed higher neurocognitive deviation in attention and motor skills, higher frequency (84%) of brain white matter lesions, and higher PVL median (range) 8.45 (0.5-71.4) copies/100 PBMC. Brain white matter lesion was associated with verbal memory deficit in HTLV-1-infected individuals (HAM/TSP and asymptomatic carriers) (p = 0.026). In addition, there was a correlation between higher PVL and neurocognitive dysfunction score (processing speed of visuomotor information and visuoconstructive praxis) in HTLV-1-infected patients. The study demonstrates an association between HTLV-1 infection, neurocognitive disorder, and white matter brain lesions on MRI as well as a correlation with higher HTLV-1 PVL, suggesting that the central nervous system involvement by HTLV-1 is not restricted to the spinal cord but involves the whole neuro-axis. HTLV-1-infected individuals should be tested for cognitive impairment.
© 2021. Journal of NeuroVirology, Inc.

Entities:  

Keywords:  Cognitive impairment; HTLV-1; HTLV-1-associated myelopathy; Magnetic resonance imaging; Tropical spastic paraparesis

Mesh:

Year:  2021        PMID: 33528826     DOI: 10.1007/s13365-021-00944-6

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  2 in total

1.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.

Authors:  M F Folstein; S E Folstein; P R McHugh
Journal:  J Psychiatr Res       Date:  1975-11       Impact factor: 4.791

2.  Cognitive impairment is frequent among symptomatic carriers of human T-cell lymphotropic virus type 1 (HTLV-1), regardless of their clinical status.

Authors:  M R P Gascón; J Casseb; J Smid; J E Vidal; L A M Fonseca; A Paiva; M J Haziot; A C Penalva de Oliveira
Journal:  J Neurol Sci       Date:  2017-04-13       Impact factor: 3.181

  2 in total
  2 in total

Review 1.  Cerebral and spinal cord changes observed through magnetic resonance imaging in patients with HTLV-1-associated myelopathy/tropical spastic paraparesis: a systematic review.

Authors:  Ana Patrícia Bastos Ferreira; Ana Dolores Firmino Santos do Nascimento; Pedro Augusto Sampaio Rocha-Filho
Journal:  J Neurovirol       Date:  2022-01-03       Impact factor: 2.643

2.  Selective visuoconstructional impairment following mild COVID-19 with inflammatory and neuroimaging correlation findings.

Authors:  Jonas Jardim de Paula; Rachel E R P Paiva; Nathália Gualberto Souza-Silva; Daniela Valadão Rosa; Fabio Luis de Souza Duran; Roney Santos Coimbra; Danielle de Souza Costa; Pedro Robles Dutenhefner; Henrique Soares Dutra Oliveira; Sarah Teixeira Camargos; Herika Martins Mendes Vasconcelos; Nara de Oliveira Carvalho; Juliana Batista da Silva; Marina Bicalho Silveira; Carlos Malamut; Derick Matheus Oliveira; Luiz Carlos Molinari; Danilo Bretas de Oliveira; José Nélio Januário; Luciana Costa Silva; Luiz Armando De Marco; Dulciene Maria de Magalhaes Queiroz; Wagner Meira; Geraldo Busatto; Débora Marques Miranda; Marco Aurélio Romano-Silva
Journal:  Mol Psychiatry       Date:  2022-06-14       Impact factor: 13.437

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.